A012303

ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients With Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy With HER2 Blockade

Status:

OPEN TO ACCRUAL

Trial Type:
Age Group:
Adults
Phase:

III

NCT Number:
Contact:

Graff, Stephanie